NASDAQ
SRZNW

Surrozen Inc. Warrant

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Surrozen Inc. Warrant Stock Price

Vitals

Today's Low:
$0.0425
Today's High:
$0.05
Open Price:
$0.05
52W Low:
$0.0212
52W High:
$0.359
Prev. Close:
$0.0498
Volume:
0

Company Statistics

Market Cap.:
$0
Book Value:
-3.026
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-39.23%
Return on Equity TTM:
-85.33%

Company Profile

Surrozen Inc. Warrant had its IPO on 2021-08-12 under the ticker symbol SRZNW.

The company operates in the Healthcare sector and Biotechnology industry. Surrozen Inc. Warrant has a staff strength of 0 employees.

Stock update

Shares of Surrozen Inc. Warrant opened at $0.05 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.04 - $0.05, and closed at $0.05.

This is a -6.83% slip from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Surrozen Inc. Warrant have increased by +12.9%.

Surrozen Inc. Warrant's Key Ratios

Surrozen Inc. Warrant has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Surrozen Inc. Warrant’s revenue was $0 with a gross profit of $0 and an EBITDA of $-43245000. The EBITDA ratio measures Surrozen Inc. Warrant's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Surrozen Inc. Warrant’s operating margin was 0% while its return on assets stood at -39.23% with a return of equity of -85.33%.

In Q2, Surrozen Inc. Warrant’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Surrozen Inc. Warrant’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-5.695 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Surrozen Inc. Warrant’s profitability.

Surrozen Inc. Warrant stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Surrozen Inc. Warrant stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$64.00 million
Total Liabilities
$6.45 million
Operating Cash Flow
$0
Capital Expenditure
$83000
Dividend Payout Ratio
0%

Surrozen Inc. Warrant ended 2024 with $64.00 million in total assets and $0 in total liabilities. Its intangible assets were valued at $64.00 million while shareholder equity stood at $55.06 million.

Surrozen Inc. Warrant ended 2024 with $0 in deferred long-term liabilities, $6.45 million in other current liabilities, 3000.00 in common stock, $-202337000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $36.50 million and cash and short-term investments were $53.40 million. The company’s total short-term debt was $2,364,000 while long-term debt stood at $0.

Surrozen Inc. Warrant’s total current assets stands at $57.58 million while long-term investments were $0 and short-term investments were $16.90 million. Its net receivables were $1.98 million compared to accounts payable of $186000.00 and inventory worth $0.

In 2024, Surrozen Inc. Warrant's operating cash flow was $0 while its capital expenditure stood at $83000.

Comparatively, Surrozen Inc. Warrant paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.05
52-Week High
$0.359
52-Week Low
$0.0212
Analyst Target Price
$

Surrozen Inc. Warrant stock is currently trading at $0.05 per share. It touched a 52-week high of $0.359 and a 52-week low of $0.359. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.05 and 200-day moving average was $0.15 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Surrozen Inc. Warrant

The stock symbol (also called stock or share ticker) of Surrozen Inc. Warrant is SRZNW

The IPO of Surrozen Inc. Warrant took place on 2021-08-12

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$109.7
-1.11
-1%
$41.33
1.16
+2.89%
$58.75
-4.28
-6.79%
$175.5
-12.35
-6.57%
$456.75
-15.2
-3.22%
$1832.8
-166.05
-8.31%
Digicontent Limited (DGCONTENT)
$20.1
-0.35
-1.71%
$50.92
8.48
+19.98%
$0.87
-0.01
-0.57%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body’s existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 that stimulates hepatocyte regeneration, improves liver function, and reduces fibrosis; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are highly expressed in intestinal crypts. The company was founded in 2016 and is headquartered in South San Francisco, California.

Address

171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080